Therapeutically optimal values in oral anticoagulation
Loeliger, E.A.; van Dijk-Wierda, C.A.
Nederlands Tijdschrift Voor Geneeskunde 121(31): 1242-1243
1977
ISSN/ISBN: 0028-2162 PMID: 895907 Document Number: 117339
Document emailed within 1 workday
Related Documents
Prandoni, P.; Piovella, C.; Spiezia, L.; Dalla Valle, F.; Pesavento, R. 2011: Optimal duration of anticoagulation in patients with venous thromboembolism Indian Journal of Medical Research 134: 15-21Hoover, H.C.; Jones, D.; Ketcham, A.S. 1976: The optimal level of anticoagulation for decreasing experimental metastases Surgery 79(6): 625-630
Tripodi, A.; Cattaneo, M.; Molteni, A.; Cesana, B.M.; Mannucci, P.M. 1998: Changes of prothrombin fragment 1+2 (F 1+2) as a function of increasing intensity of oral anticoagulation--considerations on the suitability of F 1+2 to monitor oral anticoagulant treatment Thrombosis and Haemostasis 79(3): 571-573
Alvi, A.R.; Bibi, S.; ur Rehman, Z.; Niazi, S.K. 2010: Acute mesenteric, portal and inferior vena cava (IVC) venous thrombosis: optimal outcome achieved with anticoagulation JPMA. Journal of the Pakistan Medical Association 60(5): 397-399
Chen, W.-H.; Lau, C.-P.; Lau, Y.-K.; Ng, W.; Lee, P.-Y.; Yu, C.-M.; Ma, E. 2002: Stable and optimal anticoagulation is achieved with a single dose of intravenous enoxaparin in patients undergoing percutaneous coronary intervention Journal of Invasive Cardiology 14(8): 439-442
von Bertrab, R. 1985: Is optimal anticoagulation possible in ambulatory practice? Report on a retrospective 5-year study of a cardiology practice Schweizerische Medizinische Wochenschrift 115(31-32): 1092-1105
Durán Parrondo, C.; Rodríguez Moreno, C.; Tato Herrero, F.; Alonso Vence, N.; Lado Lado, F.L. 2003: Oral anticoagulation Anales de Medicina Interna 20(7): 377-384
Avello, A.G.; César, J.; Pardo Vigo, A.; Frade, L.J.; Sánchez Godoy, P.; Navarro, J.L. 1984: Hemorrhage in oral anticoagulation Revista Clinica Espanola 172(6): 315-318
Virjo, I.; Isokoski, M. 1998: Oral anticoagulation therapy Duodecim; Laaketieteellinen Aikakauskirja 114(15): 1518-1519
Rochat, S.; Büla, C. 2005: Oral anticoagulation in elderly people Revue Medicale Suisse 1(39): 2505-2506; 2509-2511
Duckert, F.; Marbet, G.A. 1977: Control of oral anticoagulation--therapeutic range Schweizerische Medizinische Wochenschrift 107(37): 1308
Camp-Wachsmuth, M.; Humair, J.-P.; Boehlen, F. 2009: Advantages of capillary INR monitoring for oral anticoagulation Revue Medicale Suisse 5(218): 1864-1867
Ikeda, U.; Shimada, K. 2001: Oral anticoagulation therapy during and after coronary angioplasty Circulation 104(24): E150
Spyropoulos, A.C. 2005: Bridging of oral anticoagulation therapy for invasive procedures Current Hematology Reports 4(5): 405-413
Nuevo González, J.A.; Cano Ballesteros, J.C.; Pintor Holguín, E.; Braun Saro, B.; Visús Soler, E.; Sevillano Fernández, J.A. 2008: Oral anticoagulation excess: analysis from an emergency department Revista Clinica Espanola 208(2): 66-70
Kumar, P.R.; Bherappa; Satyanaryana, G.; Jaishanker, S. 1997: Intestinal intussusception as an unusual complication of oral anticoagulation therapy Indian Heart Journal 49(5): 540-542
2015: Dabigatran specific antidote: new safety level in oral anticoagulation MMW Fortschritte der Medizin 157(19): 78-79
Chechi, T. 2011: Does the clinical setting matter when performing PCi in a patient on oral anticoagulation? Minerva Cardioangiologica 59(5): 407-409
Casner, P.R. 1996: Inability to attain oral anticoagulation: warfarin-rifampin interaction revisited Southern Medical Journal 89(12): 1200-1203
Key, N. 2004: Comparison of oral versus intravenous phytonadione in patients with excessive anticoagulation Current Hematology Reports 3(5): 315-316